OrthoPediatrics Corp (KIDS)
34.68
+1.08
(+3.21%)
USD |
NASDAQ |
May 07, 16:00
34.71
+0.03
(+0.09%)
After-Hours: 20:00
OrthoPediatrics SG&A Expense (Quarterly): 38.90M for March 31, 2024
SG&A Expense (Quarterly) Chart
Historical SG&A Expense (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 38.90M |
December 31, 2023 | 32.03M |
September 30, 2023 | 32.09M |
June 30, 2023 | 32.82M |
March 31, 2023 | 29.88M |
December 31, 2022 | 27.50M |
September 30, 2022 | 27.04M |
June 30, 2022 | 26.98M |
March 31, 2022 | 22.92M |
December 31, 2021 | 21.88M |
September 30, 2021 | 20.90M |
June 30, 2021 | 21.96M |
March 31, 2021 | 20.99M |
December 31, 2020 | 19.47M |
September 30, 2020 | 19.06M |
June 30, 2020 | 16.20M |
March 31, 2020 | 15.44M |
Date | Value |
---|---|
December 31, 2019 | 15.58M |
September 30, 2019 | 16.04M |
June 30, 2019 | 14.18M |
March 31, 2019 | 12.16M |
December 31, 2018 | 11.10M |
September 30, 2018 | 12.03M |
June 30, 2018 | 12.28M |
March 31, 2018 | 12.10M |
December 31, 2017 | 12.10M |
September 30, 2017 | 9.12M |
June 30, 2017 | 8.721M |
March 31, 2017 | 7.565M |
December 31, 2016 | 9.028M |
September 30, 2016 | 7.179M |
June 30, 2016 | 7.102M |
March 31, 2016 | 6.963M |
March 31, 2015 | 5.779M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
14.18M
Minimum
Jun 2019
38.90M
Maximum
Mar 2024
23.59M
Average
21.92M
Median
SG&A Expense (Quarterly) Benchmarks
Anika Therapeutics Inc | 20.34M |
The Cooper Companies Inc | 380.90M |
Staar Surgical Co | 39.45M |
NexGel Inc | 1.22M |
Innovative Eyewear Inc | 2.160M |